Tag: psychiatric
-
Trial Shows Results for Depression Drug with Therapy
Findings from a clinical trial show an experimental drug helps people in therapy for major depression reduce their symptoms compared to a placebo.
-
Trial Shows Psilocybin Drug Helps Reduce Depression
A clinical trial shows a drug derived from the hallucinogenic compound psilocybin reduces symptoms of depression, when part of a therapy program.
-
Clinician Guidance App Designed for Depression
Neuroscientists and a software company designed a smartphone app to help front-line professionals diagnose and start treatment for patients with depression.
-
Precision Neuroscience Company Starts-Up, Raises $500M
A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science.
-
Digital Biofeedback Device Shown to Reduce PTSD
Results from a clinical trial show an electronic device reporting carbon dioxide content in breath helps people with PTSD reduce symptoms of the disorder.
-
Biotechs Partner on Agitation Detection Technology
Two developers of treatments and tools for neurological diseases are developing a system for early detection of agitation, a symptom of psychiatric disorders.
-
Psychedelic Therapy Company Raises $80M in New Funds
A developer of drugs from psychedelic compounds for mental health conditions is raising $80 million in its second venture funding round.
-
Trial Tests Psychedelic Drug Safety, Chemical Activity
A clinical trial is underway that tests an hallucinogenic compound among healthy adults as a potential treatment for mental health disorders.
-
Trial Underway Testing Suicide-Prevention Nasal Spray
A clinical trial testing a nasal spray against a placebo to prevent suicide from depression enrolled its first participants considered at high risk of suicide.
-
Mental Health Requests Rise During Pandemic
An analysis of health records shows requests for mental health services increased markedly during the early months of the Covid-19 pandemic.